 Zee News | FDA Conducting Safety Review Of Anti-Nausea Drug Zofran Wall Street Journal FDA said Zofran might raise the risk of developing abnormal changes in the electrical activity of the heart, which can cause abnormal and potentially fatal heart rhythms. FDA said GlaxoSmithKline is currently conducting a study on whether Zofran … Anti-nausea drug may pose risk to heart rhythm: FDA Zofran Side Effects Linked to Heart Rhythm Problems, FDA Warns Ondansetron Linked to Arrhythmias, FDA Warns |
FDA Conducting Safety Review Of Anti-Nausea Drug Zofran – Wall Street Journal
September 18, 2011
